Evidence map›Paper›PMID 35142154›Full record

ArticleHaematologica2022

Abhishek A Mangaonkar, Terra L Lasho, Christy Finke, Rhett P Ketterling, Kaaren K Reichard, Kristen McCullough, Naseema Gangat, Aref Al-Kali, Kebede H Begna, William H Hogan and 11 more

Abstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Epigenetic alterations in Myeloid Malignancies.Advances in experimental medicine and biology · 2026
    Review
  3. Prognostic impact ofHaematologica · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Abhishek A MangaonkarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Terra L LashoDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Christy FinkeDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Rhett P KetterlingDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester.
Kaaren K ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester.
Kristen McCulloughDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Aref Al-KaliDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Kebede H BegnaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
William H HoganDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Mark R LitzowDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Hassan AlkhateebDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Mithun ShahDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Animesh PardananiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester.
Najla H Al AliDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Chetasi TalatiDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
David SallmanDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Eric PadronDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Rami KomrokjiDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL. Rami.Komrokji@moffitt.org.
Mrinal M PatnaikDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester. patnaik.mrinal@mayo.edu.

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002377
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myelodysplastic-Myeloproliferative DiseasesMyelodysplastic SyndromesNeoplasmsHumansMutationPhosphoproteinsPrognosisRNA Splicing FactorsPhosphoproteinsRNA Splicing FactorsSF3B1 protein, human

Identifiers

PMID35142154
PMCPMC9052897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.